Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2012-08-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1213343109PMID 22927400PMCID PMC3479583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver-specific p70 S6 Kinase Depletion Protects against Hepatic Steatosis and Systemic Insulin Resistance*

  2012cited by this paper
• Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

  2012cited by this paper
• mTOR Signaling.

  2012influential reference
• Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1

  2012cited by this paper
• Insulin signaling to hepatic lipid metabolism in health and disease

  2011cited by this paper
• Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

  2011cited by this paper
• Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

  2010influential reference
• Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c

  2010cited by this paper
• The Akt-SREBP nexus: cell signaling meets lipid metabolism.

  2010cited by this paper
• Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins

  2007influential reference
• Protein sensors for membrane sterols.

  2006cited by this paper
• Posttranslational processing of SREBP-1 in rat hepatocytes is regulated by insulin and cAMP.

  2005cited by this paper
• Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c.

  2005cited by this paper
• Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

  2004cited by this paper
• Molecular mediators of hepatic steatosis and liver injury.

  2004cited by this paper
• Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.

  2004cited by this paper
• SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

  2002cited by this paper
• Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

  2000cited by this paper
• Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.

  1999cited by this paper
• Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes.

  1999cited by this paper
• The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

  1997cited by this paper
• SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

  1994cited by this paper

• Balancing cholesterol metabolism in the liver and gut: perspectives in health and disease.

  2026cites this paper
• Effects of Caloric Restriction Combined With Exercise on Lipid Metabolism and Blood Pressure: A Systematic Review and Network Meta-Analysis.

  2026cites this paper
• [EVA1A overexpression improves non-alcoholic fatty liver disease in mice by regulating lipid metabolism and promoting lipophagy].

  2026cites this paper
• ATF3-SLC7A7 Axis Regulates mTORC1 Signaling to Suppress Lipogenesis and Tumorigenesis in Hepatocellular Carcinoma

  2025cites this paper
• Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications

  2025cites this paper
• Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis

  2025cites this paper
• Therapeutic strategies targeting SREBP transcription factors: an update to 2024

  2025cites this paper
• EVA1A Regulates Hepatic Lipid Homeostasis by Modulating CD36 Expression and Its Palmitoylation

  2025cites this paper
• White Adipocyte Stem Cell Expansion Through Infant Formula Feeding: New Insights into Epigenetic Programming Explaining the Early Protein Hypothesis of Obesity

  2025cites this paper
• Amino acid-mTOR pathway-associated transcription factor GATAβ4 regulates storage protein expression in Bombyx mori.

  2025cites this paper
• Squalene: A High‐Value Compound for COVID‐19 Vaccine Adjuvants and Beyond Pathways, Production Strategies, and Market Potential

  2025cites this paper
• Lipolysis-derived fatty acids are needed for homeostatic control of sterol element-binding protein-1c driven hepatic lipogenesis

  2025influential citation
• Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications

  2025cites this paper
• Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling.

  2025cites this paper
• The Functional Interaction Between PRDM16 and the SREBP Pathway Controls Lipid Metabolism

  2025cites this paper
• Assessment of SREBP Activation Using a Microsomal Vesicle Budding Assay

  2024cites this paper
• Phosphatidic acid directly activates mTOR and then regulates SREBP to promote ganoderic acid biosynthesis under heat stress in Ganoderma lingzhi

  2024cites this paper
• Viscosol Treatment Ameliorates Insulin-Mediated Regulation of Dyslipidemia, Hepatic Steatosis, and Lipid Metabolism by Targeting PTP1B in Type-2 Diabetic Mice Model

  2024cites this paper
• Glycerol Kinase Drives Hepatic de novo Lipogenesis and Triglyceride Synthesis in Nonalcoholic Fatty Liver by Activating SREBP‐1c Transcription, Upregulating DGAT1/2 Expression, and Promoting Glycerol Metabolism

  2024cites this paper
• mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b

  2024cites this paper
• Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways

  2024cites this paper
• Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids

  2024cites this paper
• DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER

  2024cites this paper
• PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy.

  2024cites this paper
• A host enzyme reduces metabolic dysfunction-associated steatotic liver disease (MASLD) by inactivating intestinal lipopolysaccharide

  2024cites this paper
• Research Progress on the Mechanism of Milk Fat Synthesis in Cows and the Effect of Conjugated Linoleic Acid on Milk Fat Metabolism and Its Underlying Mechanism: A Review

  2024cites this paper
• Pharmacological inhibition of macrophage triglyceride biosynthesis pathways does not improve Mycobacterium tuberculosis control in infected mice

  2024cites this paper
• mTORC1, the maestro of cell metabolism and growth

  2024cites this paper
• A cholesterol-binding bacterial toxin provides a strategy for identifying a specific Scap inhibitor that blocks lipid synthesis in animal cells

  2024cites this paper
• Les voies de signalisation régulées par la disponibilité en acides aminés : contrôle de fonctions physiologiques et impacts en santé

  2024cites this paper
• RAP1A suppresses hepatic steatosis by regulating amino acid-mediated mTORC1 activation

  2024cites this paper
• Nutraceutical and Dietary Measures with Potential for Preventing/Controlling Non-Alcoholic Fatty Liver Disease and Its Complications

  2024cites this paper
• Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma

  2024cites this paper
• Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy.

  2024cites this paper
• Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis.

  2023cites this paper
• Cell lipid biology in infections: an overview

  2023cites this paper
• Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models

  2023cites this paper
• Liver insulinization as a driver of triglyceride dysmetabolism

  2023cites this paper
• Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis Development

  2023cites this paper
• Insulin Regulation of Hepatic Lipid Homeostasis.

  2023cites this paper
• The mTOR signaling pathway in cardiac aging

  2023cites this paper
• Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes

  2023influential citation
• Physiological and pathological roles of lipogenesis

  2023cites this paper
• Hepatic Insulin Resistance Model in the Male Wistar Rat Using Exogenous Insulin Glargine Administration

  2023influential citation
• Effects of dietary soybean lecithin on growth performances, body composition, serum biochemical parameters, digestive and metabolic abilities in largemouth bass Micropterus salmoides

  2023cites this paper
• Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease

  2023cites this paper
• Malic Enzyme 1 as a Novel Anti‐Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury

  2023cites this paper
• Differences in serum selenoprotein P profile between C57BL/6 and BALB/c mice fed high-fat diet.

  2023cites this paper
• The role of lysosomes in lipid homeostasis

  2023cites this paper
• SREBP1 deficiency diminishes glutamate-mediated HT22 cell damage and hippocampal neuronal pyroptosis induced by status epilepticus

  2023cites this paper
• Regulation and targeting of SREBP-1 in hepatocellular carcinoma

  2023influential citation
• Finishing the egg.

  2023cites this paper
• FAM120A couples SREBP-dependent transcription and splicing of lipogenesis enzymes downstream of mTORC1.

  2023cites this paper
• Signaling pathways and intervention for therapy of type 2 diabetes mellitus

  2023cites this paper
• Gymnema Sylvestre Supplementation Restores Normoglycemia, Corrects Dyslipidemia, and Transcriptionally Modulates Pancreatic and Hepatic Gene Expression in Alloxan-Induced Hyperglycemic Rats

  2023cites this paper
• Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice.

  2023cites this paper
• Hepatic insulin receptor: new views on the mechanisms of liver disease.

  2023cites this paper
• Insulin activates LC-PUFA biosynthesis of hepatocytes by regulating the PI3K/Akt/mTOR/Srebp1 pathway in teleost Siganus canaliculatus.

  2022cites this paper
• Paradoxical activation of SREBP1c and de novo lipogenesis by hepatocyte-selective ACLY depletion in obese mice

  2022cites this paper
• Timosaponin A3 Inhibits Palmitate and Stearate through Suppression of SREBP-1 in Pancreatic Cancer

  2022cites this paper
• Chylomicron production is repressed by RPTOR knockdown, R-α-lipoic acid and 4-phenylbutyric acid in human enterocyte-like Caco-2 cells.

  2022cites this paper
• Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice

  2022cites this paper
• The role of SHMT2 in modulating lipid metabolism in hepatocytes via glycine-mediated mTOR activation

  2022cites this paper
• Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia.

  2022cites this paper
• mTORC1 beyond anabolic metabolism: Regulation of cell death

  2022cites this paper
• The prerequisites for the development of type 2 diabetes or prediabetes in rats fed a high-fat diet

  2022cites this paper
• Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease

  2022cites this paper
• Effects of in ovo feeding of t10,c12-conjugated linoleic acid on hepatic lipid metabolism and subcutaneous adipose tissue deposition in newly hatched broiler chicks

  2022cites this paper
• LXR Acts as a Differentiator in the Regulation of FAS and G6PDH Gene Expression Under Insulin Resistant Conditions

  2022influential citation
• Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis

  2022cites this paper
• Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD.

  2022cites this paper
• Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development

  2021cites this paper
• Regulation and metabolic functions of mTORC1 and mTORC2.

  2021cites this paper
• Selective abrogation of S6K2 maps lipid homeostasis as a survival vulnerability in MAPKi-resistant NRASMUT melanoma

  2021cites this paper
• Dysregulated SREBP1c/miR-153 signaling induced by hypertriglyceridemia worsens acute pancreatitis and delays tissue repair

  2021cites this paper
• Ilexgenin A restrains CRTC2 in the cytoplasm to prevent SREBP1 maturation via AMP kinase activation in the liver

  2021cites this paper
• Hepatic transcriptional responses to fasting and feeding

  2021cites this paper
• Enterocyte superoxide dismutase 2 deletion drives obesity

  2021cites this paper
• Investigation of the hepatic mTOR/S6K1/SREBP1 signalling pathway in rats at different ages: from neonates to adults

  2021cites this paper
• L-theanine prevents progression of nonalcoholic hepatic steatosis by regulating hepatocyte lipid metabolic pathways via the CaMKKβ-AMPK signaling pathway

  2021cites this paper
• SREBP-1c and lipogenesis in the liver: an update1.

  2021cites this paper
• Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease via Inhibiting the mTORC1/SREBP-1c Pathway.

  2021cites this paper
• Dihydroartemisinin ameliorates retinal vascular dysfunction in diabetes mellitus via FASN/Kmal-mTOR/SREBP1 feedback loop.

  2021cites this paper
• The beneficial effects of taurine in alleviating fatty liver disease

  2021cites this paper
• The insulin centennial—100 years of milestones in biochemistry

  2021cites this paper
• Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy

  2021cites this paper
• Development and validation of a four‐lipid metabolism gene signature for diagnosis of pancreatic cancer

  2021cites this paper
• Role of Insulin Resistance in MAFLD

  2021cites this paper
• Discovery of a potent FKBP38 agonist that ameliorates HFD-induced hyperlipidemia via mTOR/P70S6K/SREBPs pathway

  2021cites this paper
• Oral Subacute Exposure to Cadmium LOAEL Dose Induces Insulin Resistance and Impairment of the Hormonal and Metabolic Liver-Adipose Axis in Wistar Rats

  2021cites this paper
• The small GTPase Rab32 resides on lysosomes to regulate mTORC1 signaling

  2020cites this paper
• Dose-dependent and disease-modifying effects of striatal infusion of cholesterol in Huntington’s disease

  2020cites this paper
• Geniposide alleviates non‐alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways

  2020cites this paper
• Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model

  2020cites this paper
• Molecular Characterization, Nutritional and Insulin Regulation of Elovl6 in Rainbow Trout (Oncorhynchus mykiss)

  2020cites this paper
• Fatty liver diseases, mechanisms, and potential therapeutic plant medicines.

  2020cites this paper
• microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis

  2020cites this paper
• Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action.

  2020cites this paper
• Deciphering the expression dynamics of ANGPTL8 associated regulatory network in insulin resistance using formal modelling approaches

  2020cites this paper
• Osteocalcin and Non‐Alcoholic Fatty Liver Disease: Lessons From Two Population‐Based Cohorts and Animal Models

  2020cites this paper